• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Characteristics and Outcomes of Patients with Invasive Pulmonary Aspergillosis and Respiratory Tract Colonization from a Tertiary University Hospital in Thailand.泰国一所三级大学医院侵袭性肺曲霉病和呼吸道定植患者的特征与结局
J Fungi (Basel). 2022 Mar 25;8(4):344. doi: 10.3390/jof8040344.
2
Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.血清半乳甘露聚糖阴性侵袭性肺曲霉病的临床特征、影像学表现、危险因素和转归。
J Microbiol Immunol Infect. 2018 Dec;51(6):802-809. doi: 10.1016/j.jmii.2017.05.007. Epub 2017 Jun 29.
3
Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study.从呼吸道分离曲霉菌在侵袭性肺曲霉病诊断中的意义。一项为期三年的前瞻性研究结果。
Am J Med. 1986 Aug;81(2):249-54. doi: 10.1016/0002-9343(86)90259-7.
4
The Platelia Aspergillus ELISA in diagnosis of invasive pulmonary aspergilosis (IPA).普立泰利阿曲霉酶联免疫吸附测定法在侵袭性肺曲霉病(IPA)诊断中的应用。
Mycoses. 2001;44(7-8):266-72.
5
Unusual forms of subacute invasive pulmonary aspergillosis in patients with solid tumors.实体瘤患者中不同寻常形式的亚急性侵袭性肺曲霉病。
J Infect. 2014 Oct;69(4):387-95. doi: 10.1016/j.jinf.2014.03.018. Epub 2014 May 15.
6
Development of Aspergillosis in a cohort of non-neutropenic, non-transplant patients colonised by Aspergillus spp.曲霉属菌定植的非中性粒细胞减少、非移植患者队列中曲霉病的发生情况
BMC Infect Dis. 2017 Jan 6;17(1):34. doi: 10.1186/s12879-016-2143-5.
7
Aspergillus-positive lower respiratory tract samples in patients with the acute respiratory distress syndrome: a 10-year retrospective study.急性呼吸窘迫综合征患者曲霉属阳性下呼吸道样本:一项10年回顾性研究
Ann Intensive Care. 2016 Dec;6(1):52. doi: 10.1186/s13613-016-0156-2. Epub 2016 Jun 13.
8
The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.囊性纤维化患儿肺曲霉病的临床表现——初步报告
Dev Period Med. 2015 Jan-Mar;19(1):66-79.
9
Pentraxin 3 levels in bronchoalveolar lavage fluid of lung transplant recipients with invasive aspergillosis.肺移植受者侵袭性曲霉菌感染支气管肺泡灌洗液中 pentraxin 3 水平。
J Heart Lung Transplant. 2017 Sep;36(9):973-979. doi: 10.1016/j.healun.2017.04.007. Epub 2017 Apr 19.
10
Prospective observational study of respiratory Aspergillus colonization or disease in patients with various stages of chronic obstructive pulmonary disease utilizing culture versus nonculture techniques.利用培养与非培养技术对不同阶段慢性阻塞性肺疾病患者呼吸道曲霉定植或疾病的前瞻性观察研究。
Med Mycol. 2020 Sep 14. doi: 10.1093/mmy/myaa077.

引用本文的文献

1
An innovative fungal-specific targeted next-generation sequencing method: analytical performance and a single-center prospective clinical study.一种创新的真菌特异性靶向新一代测序方法:分析性能及单中心前瞻性临床研究。
J Transl Med. 2025 Jul 24;23(1):820. doi: 10.1186/s12967-025-06784-w.
2
Epidemiological characteristics of patients with invasive pulmonary aspergillosis infected with Aspergillus fumigatus from a tertiary hospital in Ningxia, China.中国宁夏某三级医院烟曲霉感染的侵袭性肺曲霉病患者的流行病学特征
Sci Rep. 2025 Apr 15;15(1):13036. doi: 10.1038/s41598-025-97587-y.
3
Clinical features and risk factors of invasive pulmonary aspergillosis in interstitial lung disease patients.间质性肺疾病患者侵袭性肺曲霉病的临床特征及危险因素
BMC Pulm Med. 2024 Dec 4;24(1):602. doi: 10.1186/s12890-024-03430-x.
4
Prevalence, Risk Factors, and Mortality of Invasive Pulmonary Aspergillosis in Patients with Anti-MDA5+ Dermatomyositis: A Retrospective Study in China.抗MDA5阳性皮肌炎患者侵袭性肺曲霉病的患病率、危险因素及死亡率:一项中国的回顾性研究
J Inflamm Res. 2024 May 20;17:3247-3257. doi: 10.2147/JIR.S460702. eCollection 2024.
5
Prognostic factors and outcomes of invasive pulmonary aspergillosis, a retrospective hospital-based study.侵袭性肺曲霉病的预后因素及结局:一项基于医院的回顾性研究
PeerJ. 2024 Feb 28;12:e17066. doi: 10.7717/peerj.17066. eCollection 2024.

本文引用的文献

1
Putative invasive pulmonary aspergillosis within medical wards and intensive care units: a 4-year retrospective, observational, single-centre study.疑似侵袭性肺曲霉病在普通病房和重症监护病房中的 4 年回顾性、观察性、单中心研究。
Intern Emerg Med. 2021 Sep;16(6):1619-1627. doi: 10.1007/s11739-021-02705-z. Epub 2021 Mar 22.
2
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.侵袭性真菌病的共识定义修订与更新:来自欧洲癌症研究与治疗组织和真菌病研究组教育与研究联合会。
Clin Infect Dis. 2020 Sep 12;71(6):1367-1376. doi: 10.1093/cid/ciz1008.
3
Invasive Pulmonary Aspergillosis in Nonimmunocompromised Hosts.非免疫功能低下宿主的侵袭性肺曲霉病。
Semin Respir Crit Care Med. 2019 Aug;40(4):540-547. doi: 10.1055/s-0039-1696968. Epub 2019 Oct 4.
4
Pathophysiological aspects of Aspergillus colonization in disease.曲霉在疾病中定殖的病理生理学方面。
Med Mycol. 2019 Apr 1;57(Supplement_2):S219-S227. doi: 10.1093/mmy/myy076.
5
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.曲霉病诊断和管理实践指南:美国感染病学会2016年更新版
Clin Infect Dis. 2016 Aug 15;63(4):e1-e60. doi: 10.1093/cid/ciw326. Epub 2016 Jun 29.
6
Aspergillus-positive lower respiratory tract samples in patients with the acute respiratory distress syndrome: a 10-year retrospective study.急性呼吸窘迫综合征患者曲霉属阳性下呼吸道样本:一项10年回顾性研究
Ann Intensive Care. 2016 Dec;6(1):52. doi: 10.1186/s13613-016-0156-2. Epub 2016 Jun 13.
7
The clinical spectrum of pulmonary aspergillosis.肺部曲霉菌病的临床谱。
Thorax. 2015 Mar;70(3):270-7. doi: 10.1136/thoraxjnl-2014-206291. Epub 2014 Oct 29.
8
What's new in invasive pulmonary aspergillosis in the critically ill.危重症患者侵袭性肺曲霉病有哪些新进展。
Intensive Care Med. 2014 May;40(5):723-6. doi: 10.1007/s00134-014-3254-3. Epub 2014 Mar 20.
9
Approach to invasive pulmonary aspergillosis in critically ill patients.危重症患者侵袭性肺曲霉病的处理方法。
Curr Opin Infect Dis. 2014 Apr;27(2):174-83. doi: 10.1097/QCO.0000000000000043.
10
Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes.重症监护病房(ICU)患者的曲霉菌病:流行病学和经济结局。
BMC Infect Dis. 2013 Jan 23;13:29. doi: 10.1186/1471-2334-13-29.

泰国一所三级大学医院侵袭性肺曲霉病和呼吸道定植患者的特征与结局

Characteristics and Outcomes of Patients with Invasive Pulmonary Aspergillosis and Respiratory Tract Colonization from a Tertiary University Hospital in Thailand.

作者信息

Soontrapa Pannathat, Chongtrakool Piriyaporn, Chayakulkeeree Methee

机构信息

Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.

Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.

出版信息

J Fungi (Basel). 2022 Mar 25;8(4):344. doi: 10.3390/jof8040344.

DOI:10.3390/jof8040344
PMID:35448575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9027169/
Abstract

Positive culture for spp. from respiratory specimens needs to be interpreted together with relevant clinical conditions/settings to differentiate invasive infection from colonization. In this study, we aimed to investigate the association between positive culture for spp. from respiratory specimens and the presence of invasive pulmonary aspergillosis. Hospitalized patients with positive culture for spp. from any respiratory sample were retrospectively recruited. Patients were classified into two groups: those with invasive pulmonary aspergillosis and those with non-invasive aspergillosis/colonization. Two hundred and forty-one patients (48.1% male; mean age: 59.8 ± 14.5 years) were included. The most common spp. was (21.0%). The most common underlying condition was chronic lung disease (23.7%), followed by solid tumor (22.4%). Myeloproliferative disease (aOR: 69.2, 95% CI: 2.4-1991.9), neutropenia ≥ 10 days (aOR: 31.8; 95% CI: 1.10-920.53), and corticosteroid treatment (aOR: 42.8, 95% CI: 6.5-281.3) were independent predictors of the invasive form. Chronic lung disease was independently inversely related to invasive form (OR: 0.04; 95% CI: 0.003-0.49). Serum galactomannan was positive in 69.2% of patients with invasive aspergillosis (OR: 25.9, 95% CI: 5.2-127.8). All inappropriately treated patients with invasive form died. In conclusion, positive culture for spp. from respiratory specimens with coexisting myeloproliferative disease, neutropenia ≥ 10 days, corticosteroid treatment, or positive serum galactomannan is highly suggestive of invasive pulmonary aspergillosis.

摘要

呼吸道标本中 spp. 的培养阳性结果需要结合相关临床情况/背景进行解读,以区分侵袭性感染和定植。在本研究中,我们旨在调查呼吸道标本中 spp. 的培养阳性与侵袭性肺曲霉病的存在之间的关联。对任何呼吸道样本中 spp. 培养阳性的住院患者进行回顾性招募。患者分为两组:侵袭性肺曲霉病患者和非侵袭性曲霉病/定植患者。共纳入241例患者(男性占48.1%;平均年龄:59.8±14.5岁)。最常见的 spp. 是 (21.0%)。最常见的基础疾病是慢性肺病(23.7%),其次是实体瘤(22.4%)。骨髓增殖性疾病(调整后比值比:69.2,95%置信区间:2.4 - 1991.9)、中性粒细胞减少≥10天(调整后比值比:31.8;95%置信区间:1.10 - 920.53)和皮质类固醇治疗(调整后比值比:42.8,95%置信区间:6.5 - 281.3)是侵袭性形式的独立预测因素。慢性肺病与侵袭性形式独立呈负相关(比值比:0.04;95%置信区间:0.003 - 0.49)。69.2%的侵袭性曲霉病患者血清半乳甘露聚糖呈阳性(比值比:25.9,95%置信区间:5.2 - 127.8)。所有侵袭性形式治疗不当的患者均死亡。总之,呼吸道标本中 spp. 培养阳性且并存骨髓增殖性疾病、中性粒细胞减少≥10天、皮质类固醇治疗或血清半乳甘露聚糖阳性高度提示侵袭性肺曲霉病。